Gout: Difference between revisions
No edit summary |
|||
| Line 26: | Line 26: | ||
==[[Treatment]]== | ==[[Treatment]]== | ||
[[Gout medical therapy|Medical Therapy | [[Gout medical therapy|Medical Therapy]] | [[Gout surgery|Surgery]] | [[Gout primary prevention|Primary Prevention]] | [[Gout secondary prevention|Secondary Prevention]] | [[Gout cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Gout future or investigational therapies|Future or Investigational Therapies]] | ||
[[Clinical practice guideline]]s inform treatment<ref name="pmid32390306">{{cite journal| author=FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM | display-authors=etal| title=2020 American College of Rheumatology Guideline for the Management of Gout. | journal=Arthritis Rheumatol | year= 2020 | volume= 72 | issue= 6 | pages= 879-895 | pmid=32390306 | doi=10.1002/art.41247 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32390306 }} </ref>. | |||
== Prognosis == | == Prognosis == | ||
Revision as of 21:52, 19 June 2020
For patient information click here
|
Gout Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gout On the Web |
|
American Roentgen Ray Society Images of Gout |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Synonyms and keywords: Urate crystal arthropathy; uric acid crystal deposition in joint; gouty arthritis; podagra
Overview
Historical Perspective
Pathophysiology
Differentiating Gout from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Clinical practice guidelines inform treatment[2].
Prognosis
Case Studies
Related Chapter
External Links
- "Answers and Questions on Gout". U.S. National Institutes of Health—National Institute of Arthritis and Musculoskeletal and Skin Diseases. September 28th, 2007. Retrieved 2007-08-28. Check date values in:
|date=(help) - "Coffee Consumption and Reduced Gout Risk". Drinking coffee reduces risk of gout in middle age men. U.S. National Institutes of Health. Retrieved 2007-05-25.
References
- ↑ Roddy, Edward (2011). "Revisiting the pathogenesis of podagra: why does gout target the foot?". Journal of Foot and Ankle Research. 4 (1). doi:10.1186/1757-1146-4-13. ISSN 1757-1146.
- ↑ FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM; et al. (2020). "2020 American College of Rheumatology Guideline for the Management of Gout". Arthritis Rheumatol. 72 (6): 879–895. doi:10.1002/art.41247. PMID 32390306 Check
|pmid=value (help).
Template:Diseases of the musculoskeletal system and connective tissue
ar:نقرس bg:Подагра cs:Dna da:Gigt de:Gicht eo:Podagro fa:نقرس io:Kiragro id:Gout it:Gotta he:שיגדון lb:Giicht ms:Gout nl:Jicht no:Urinsyregikt sk:Dna sr:Гихт fi:Kihti sv:Gikt te:గౌటు